Watch the 22 sessions from SOSV Climate Tech Summit!

Cognitive disorders such as ADHD and Alzheimer’s Disease are two of the most debilitating diseases with dementia alone causing US$680b in global economic impact. Braingaze offers a patented, scientifically and clinically validated biomarker-based decision support system for early diagnosis of dementia and Alzheimer’s and a game based digital treatment that improves patients’ cognitive health. Braingaze is working with 25 clinics and hospitals in Europe and has signed a partnership with Ping An Group for China market entry.